Consumer Information on: MEL 80? Excimer Laser System

<!– –> <!– Page Last Updated: 04/25/2011 –> Page Last Updated: 04/25/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Guidance for Industry and FDA Staff

Document issued on: April 25, 2011 The draft of this document was issued April 6, 2006 For questions regarding this guidance document, contact Charles Durfor, Ph.D., at 301-796-6438 or by email at [email protected]. U.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Devices and Radiological Health Plastic and Reconstructive Surgery Devices BranchDivision of…

FDA Drug Safety Communication: Safety update on Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)

  Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary   Safety Announcement [04-22-2011] The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection, associated with use of Tysabri (natalizumab) for the treatment of multiple sclerosis (MS) and Crohn’s disease. The…

FDA Drug Info Rounds

<!– –> <!– Page Last Updated: 04/20/2011 –> Page Last Updated: 04/20/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Consumer Information on: Pipeline? Embolization Device

<!– –> <!– Page Last Updated: 04/20/2011 –> Page Last Updated: 04/20/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.